Literature DB >> 8564648

Human cell lines in pharmacotoxicology. An introduction to a panel discussion.

A M Batt1, L Ferrari, A Abid, N Sabolović.   

Abstract

Various types of cells lines are used in pharmacotoxicology. Established cell lines are easily available, with few ethical restrictions. Some specific properties are preserved, although they have kept the phenotype of the original tissue, which is frequently a tumor phenotype. They are usually more resistant to toxic compounds than freshly isolated cells. Some drug-metabolizing enzymes are expressed and regulated in these cells. Immortalized cell lines are also of interest in toxicology. They are mainly examined for their potential in mutagenicity testing. These cells and numerous others of animal or human origin can be transfected with cDNA coding for human enzymes. They are used for determination of the individual enzyme involved in a particular metabolic pathway, or, when multiple transfections are successfully achieved, for mutagenicity testing. Regulation studies are also possible in such cells after transfection of DNA elements regulating gene transcription.

Entities:  

Mesh:

Year:  1995        PMID: 8564648     DOI: 10.1007/bf00756521

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  27 in total

1.  Expression of glutathione S-transferase and phenol sulfotransferase, but not of UDP-glucuronosyltransferase, in the human lung tumor cell lines NCI-H322 and NCI-H358.

Authors:  F J Wiebel; F Kiefer; G Krupski; H M Schuller
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

2.  Modulation of the asialoglycoprotein receptor in human hepatoma cells: effect of glucose.

Authors:  P Weiss; G Ashwell; A G Morell; R J Stockert
Journal:  Hepatology       Date:  1994-02       Impact factor: 17.425

3.  Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line.

Authors:  M H Grant; S J Duthie; A G Gray; M D Burke
Journal:  Biochem Pharmacol       Date:  1988-11-01       Impact factor: 5.858

4.  Interaction of cytokine- and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes.

Authors:  H Baumann; G P Jahreis; K K Morella
Journal:  J Biol Chem       Date:  1990-12-25       Impact factor: 5.157

5.  Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.

Authors:  B W Penman; J Reece; T Smith; C S Yang; H V Gelboin; F J Gonzalez; C L Crespi
Journal:  Pharmacogenetics       Date:  1993-02

6.  Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Authors:  T Lesuffleur; A Kornowski; C Augeron; E Dussaulx; A Barbat; C Laboisse; A Zweibaum
Journal:  Int J Cancer       Date:  1991-11-11       Impact factor: 7.396

7.  Suppression of cytochrome P450IA1 by interleukin-6 in human HepG2 hepatoma cells.

Authors:  Y Fukuda; S Sassa
Journal:  Biochem Pharmacol       Date:  1994-03-29       Impact factor: 5.858

8.  The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells.

Authors:  H Doostdar; M H Grant; W T Melvin; C R Wolf; M D Burke
Journal:  Biochem Pharmacol       Date:  1993-08-17       Impact factor: 5.858

9.  Hepatocellular carcinoma after thorotrast exposure: establishment of a new cell line (Mz-Hep-1).

Authors:  W G Dippold; H P Dienes; A Knuth; W Sachsse; W Prellwitz; D Bitter-Suermann; K H Meyer zum Büschenfelde
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

10.  The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction.

Authors:  L C Quattrochi; T Vu; R H Tukey
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.